The LEAST They Could Do: IL Parole Board Members Resign After Prisoner They...
Righteous Anger Boils Over as NYPD Union Tells City Council NOT to Attend...
Rob Reiner Says Taylor Swift Could Single-Handedly Save American Democracy
We Have So MANY Questions: Man Marries Conjoined Twin and Well, There is...
Timing of Biden-Harris Campaign's Attempted Slam on Trump is a SHAMELESS Fail
Paying Their Respects: NYT Announces Joe Lieberman's Passing With Hilarious Election Denia...
Joy Reid Dragged for Claiming GOP is Anti-DEI Because They Can't Stand Black...
Trump Steamrolls Biden, Liberals Love Losing
'Sorry the IDF Is Winning': WaPo Whines About Israeli Maps Not Showing 'Rubble,...
NYC Councilwoman Who Smeared Daniel Penny SHAMES Men for Not Calling Out Violence...
Here's a Poll Listing Biden's Positive Accomplishments and We CAN'T Disagree With the...
WATCH: As Boston Ponders Reparations, Black Churches Tell White Churches They're 'Coming f...
WI Dem State Senator and Well-Known Shoplifter Claims Nobody 'Deserves' to Be a...
CNN Host’s Segment on the Abortion Pill Doesn't Go Quite As Planned
Hilarious Community Note on Brigitte Gabriel Post Also Shows the Absolute State of...

Pfizer delays its EUA request for a 2-dose Covid vaccine for kids under 5, will wait for data on a 3-dose vaccine instead

Pfizer told the FDA on Friday that it wants a delay on the company’s EUA request for a two-dose Covid vaccine for children under five. . .

Advertisement

. . .and that’s because Pfizer thinks three doses “may provide a higher level of protection in this age group”:

Here’s the statement from the FDA:

The U.S. Food and Drug Administration has been notified by Pfizer that new data have recently emerged regarding its emergency use authorization request for the use of the Pfizer-BioNTech COVID-19 Vaccine in children 6 months through 4 years of age. As part of its rolling submission, the company recently notified the agency of additional findings from its ongoing clinical trial. Based on the agency’s preliminary assessment, and to allow more time to evaluate additional data, we believe additional information regarding the ongoing evaluation of a third dose should be considered as part of our decision-making for potential authorization.

Advertisement

Something just doesn’t add up here, right?

The FDA was going to meet on February 15 to discuss the authorization for this age group:

Pfizer expects to have data from the three-dose vaccine in April:

Advertisement

In other words, “back to the drawing board”:

Do you mean to tell us our health experts have a messaging problem?

***

Join the conversation as a VIP Member

Recommended

Trending on Twitchy Videos

Advertisement
Advertisement
Advertisement